Beta Bionics, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$4,632,545
36 notices · 235,337 sh
Oct 2025 to Oct 2026
Reported ·
$1,990,145
34 sales · 0 buys
Oct 2025 to Jun 2026
The two figures cover different periods.
20 of 34 reported sales carry the 10b5-1 box. Together they are 0.22% of the shares on issue.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-10-01MARK HOPMAN, Chief Commercial Officer$50,487
2026-09-22CHRISTINA JONES, Director$197,082
2026-09-16MICHAEL MENSINGER, Chief Product Officer$101,919
2026-09-16MARK HOPMAN, Chief Commercial Officer$540,728
2026-09-09MARK HOPMAN, Chief Commercial Officer$779,096
2026-09-03Sean Saint, President & CEO$113,259
2026-09-02Steven Jon Russell, Chief Medical Officer$81,951
2026-09-02Sean Saint, President & CEO$327,473
2026-09-02Stephen Feider, Chief Financial Officer$129,595
2026-09-02Michael R. Mensinger, Chief Product Officer$84,941
2026-09-02Mark Hopman, Chief Commercial Officer$103,424
2026-06-29Stephen Feider, Chief Financial Officer$83,381
2026-06-26Stephen Feider, Chief Financial Officer$87,007
Form 4, 2026-06-30: sold 10,000 at $17.04 Form 4 ↗
2026-06-24CHRISTINA JONES, Director$19,220
Form 4, 2026-06-25: sold 1,406 at $15.00 Form 4 ↗
2026-06-24Mark Hopman, Chief Commercial Officer$18,827
Form 4, 2026-06-25: sold 1,258 at $15.01 Form 4 ↗
2026-06-04CHRISTINA JONES, Director$34,997
Form 4, 2026-06-05: sold 2,811 at $14.00 Form 4 ↗
2026-06-04Mark Hopman, Chief Commercial Officer$3,385
Form 4, 2026-06-05: sold 275 at $12.31 Form 4 ↗
2026-06-02Steven Jon Russell, Chief Medical Officer$53,999
Form 4, 2026-06-03: sold 4,222 at $12.61 Form 4 ↗
2026-06-02Sean Saint, President & CEO$215,793
Form 4, 2026-06-03: sold 16,872 at $12.61 Form 4 ↗
2026-06-02Stephen Feider, Chief Financial Officer$85,386
Form 4, 2026-06-03: sold 6,676 at $12.61 Form 4 ↗
2026-06-02Michael R. Mensinger, Chief Product Officer$55,995
Form 4, 2026-06-03: sold 4,378 at $12.61 Form 4 ↗
2026-06-02Mark Hopman, Chief Commercial Officer$68,158
Form 4, 2026-06-03: sold 5,329 at $12.61 Form 4 ↗
2026-05-21CHRISTINA JONES, Director$20,200
Form 4, 2026-05-26: sold 1,998 at $9.95 Form 4 ↗
2026-05-21ADAM LEZACK, Director$20,200
Form 4, 2026-05-26: sold 1,998 at $10.58 Form 4 ↗
2026-03-04Mark Hopman, Chief Commercial Officer$4,084
Form 4, 2026-03-05: sold 353 at $11.57 Form 4 ↗
2026-03-02Sean Saint, President & CEO$42,368
Form 4, 2026-03-03: sold 3,384 at $12.36 Form 4 ↗
2026-03-02Stephen Feider, Chief Financial Officer$17,879
Form 4, 2026-03-03: sold 1,428 at $12.36 Form 4 ↗
2026-03-02Michael R. Mensinger, Chief Product Officer$13,321
Form 4, 2026-03-03: sold 1,064 at $12.36 Form 4 ↗
2026-01-02MICHAEL MENSINGER, Chief Product Officer$304,700
Form 4, 2026-01-05: sold 7,800 at $29.61 Form 4 ↗
2026-01-02Stephen Feider, Chief Financial Officer$590,680
Form 4, 2026-01-05: sold 20,000 at $29.53 Form 4 ↗
2025-12-04Mark Hopman, Chief Commercial Officer$63,192
Form 4, 2026-03-16: sold 2,917 at $30.27 Form 4 ↗
2025-12-02Sean Saint, President & CEO$96,163
Form 4, 2025-12-04: sold 3,278 at $29.34 Form 4 ↗
2025-12-02Stephen Feider, Chief Financial Officer$41,862
Form 4, 2025-12-04: sold 1,427 at $29.34 Form 4 ↗
2025-12-02Michael R. Mensinger, Chief Product Officer$31,184
Form 4, 2025-12-04: sold 1,063 at $29.34 Form 4 ↗
2025-10-31ADAM LEZACK, Director$75,305
Form 4, 2025-11-05: sold 1,406 at $26.87 Form 4 ↗